Highlights from the 2006 AACR Plenary Session

OncoLink's John Plastaras, MD reports on the April 1-5, 2006 meeting "Breakthroughs in Clinical Research" in Washington DC.
A phase III, multicenter, randomized controlled trial of panitumumab plus best supportive care (BSC) versus BSC alone in patients with metastatic colorectal cancer
Celecoxib reduces sporadic colorectal adenomas: Results from the Adenoma Prevention with Celecoxib (APC) trial
Chemoprevention of colorectal adenomas with celecoxib in an international, randomized, placebo-controlled, double-blind trial
Development of the ABL kinase inhibitor dasatinib (BMS-354825) in imatinib-resistant Philadelphia chromosome-positive leukemias

AACR: Advances Show Promise for Variety of Cancers

Sep 2, 2014 - Cutting-edge research is rapidly moving from bench to bedside in a variety of cancers, according to four studies highlighted this week at a press conference presented at the 100th Annual Meeting of the American Association for Cancer Research held from April 18 to 22 in Denver.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More